AU1341092A - Regulation of nucleic acid translation - Google Patents

Regulation of nucleic acid translation

Info

Publication number
AU1341092A
AU1341092A AU13410/92A AU1341092A AU1341092A AU 1341092 A AU1341092 A AU 1341092A AU 13410/92 A AU13410/92 A AU 13410/92A AU 1341092 A AU1341092 A AU 1341092A AU 1341092 A AU1341092 A AU 1341092A
Authority
AU
Australia
Prior art keywords
rna
region
responsive
responsive rna
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13410/92A
Other languages
English (en)
Inventor
Robert L Lechner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Biochemical Corp
Original Assignee
United States Biochemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Biochemical Corp filed Critical United States Biochemical Corp
Publication of AU1341092A publication Critical patent/AU1341092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU13410/92A 1991-01-25 1992-01-24 Regulation of nucleic acid translation Abandoned AU1341092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64610991A 1991-01-25 1991-01-25
US646109 1991-01-25

Publications (1)

Publication Number Publication Date
AU1341092A true AU1341092A (en) 1992-08-27

Family

ID=24591791

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13410/92A Abandoned AU1341092A (en) 1991-01-25 1992-01-24 Regulation of nucleic acid translation

Country Status (7)

Country Link
EP (1) EP0568641A4 (ja)
JP (1) JPH06505161A (ja)
AU (1) AU1341092A (ja)
CA (1) CA2100251A1 (ja)
IE (1) IE920229A1 (ja)
PT (1) PT100052A (ja)
WO (1) WO1992013070A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4234293A (en) * 1992-05-14 1993-12-13 Ribozyme Pharmaceuticals, Inc. Virus resistant plants containing inducible cytotoxic mrnas
EP0707638A4 (en) * 1992-12-04 1998-05-20 Innovir Lab Inc REGULABLE NUCLEIC ACID FOR THERAPEUTIC USE AND METHODS OF USE THEREOF
AU8088794A (en) * 1993-10-25 1995-05-22 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Plasmids for efficient expression of synthetic genes in (e. coli)
US5631148A (en) * 1994-04-22 1997-05-20 Chiron Corporation Ribozymes with product ejection by strand displacement
BR9810460A (pt) 1997-06-25 2001-11-27 Charles Allen Black Jr Cassete de expressão mascarado e métodos paracontrolar a expressão e produzir uma proteìnade interesse
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CZ295108B6 (cs) 1998-03-20 2005-05-18 Benitec Australia Ltd Syntetický gen obsahující dispergovanou nebo cizorodou deoxyribonukleovou molekulu a genový konstrukt obsahující tento syntetický gen
US8598332B1 (en) 1998-04-08 2013-12-03 Bayer Cropscience N.V. Methods and means for obtaining modified phenotypes
ATE507299T1 (de) 1998-04-08 2011-05-15 Commw Scient Ind Res Org Verfahren und mittel zum erhalt von veränderten phänotypen
US20040214330A1 (en) 1999-04-07 2004-10-28 Waterhouse Peter Michael Methods and means for obtaining modified phenotypes
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP3218483A4 (en) 2014-11-14 2018-07-18 Ionis Pharmaceuticals, Inc. Compounds and methods for the modulation of proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820639A (en) * 1985-12-04 1989-04-11 Massachusetts Institute Of Technology Process for enhancing translational efficiency of eukaryotic mRNA
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
WO1989000604A1 (en) * 1987-07-13 1989-01-26 Interferon Sciences, Inc. Method for improving translation efficiency

Also Published As

Publication number Publication date
EP0568641A1 (en) 1993-11-10
CA2100251A1 (en) 1992-07-26
PT100052A (pt) 1993-03-31
JPH06505161A (ja) 1994-06-16
WO1992013070A1 (en) 1992-08-06
IE920229A1 (en) 1992-07-29
EP0568641A4 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
EP0291533B1 (en) Rna ribozyme restriction endoribonucleases and methods
Woodson et al. Reverse self-splicing of the Tetrahymena group I intron: implication for the directionality of splicing and for intron transposition
US5712128A (en) Enzymatic RNA molecules
KR100235792B1 (ko) 트랜스-스플라이싱 리보자임
US9012140B2 (en) Target-dependent nucleic acid adapter
US5631148A (en) Ribozymes with product ejection by strand displacement
Heidenreich et al. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.
Chetverina et al. Spontaneous rearrangements in RNA sequences
JPH10508181A (ja) リボヌクレアーゼｐ標的化および切断配列を用いるｒｎａの標的化切断
JPH10510165A (ja) Ｄｎａ酵素分子
AU4119893A (en) Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
AU1341092A (en) Regulation of nucleic acid translation
Doudna et al. Miniribozymes, small derivatives of the sunY intron, are catalytically active
AU2006317222B2 (en) DNA constructs for specific inhibition of gene expression by RNA interference
WO1993023532A1 (en) VIRUS RESISTANT PLANTS CONTAINING INDUCIBLE CYTOTOXIC mRNAs
Attal et al. Effect of intercistronic length on internal ribosome entry site (IRES) efficiency in bicistronic mRNA
US5912149A (en) Multimeric self-cleaving ribozyme
van Dijk et al. Distinct RNA structural domains cooperate to maintain a specific cleavage site in the 3′-UTR of IGF-II mRNAs
Grivell Transposition: Mobile introns get into line
CA2289907C (en) Eukaryotic and retroviral antisense initiator elements
Schneppe et al. Translation of the first gene of the Escherichia coli unc operon. Selection of the start codon and control of initiation efficiency.
Deng et al. Catalytic RNA reactions of yeast tRNAPhe fragments
Bovenberg et al. In vitro splicing analysis of mini-gene constructs of the alternatively processed human calcitonin/CGRP-I pre-mRNA
AU708673B2 (en) Enzymatic RNA molecules
US7211661B2 (en) Trans-excision-splicing ribozyme and methods of use